Clinical Trials Logo

Clinical Trial Summary

The Ventricular septal defect (VSD) is the most common of all congenital cardiac malformations. By modifying the Nit-Occlud® PDA Device the Nit-Occlud® Lê VSD Spiral System was designed. as a percutaneous, transcatheter device for occlusion of (peri)membranous and muscular ventricular septum defects (VSD) with a spiral coil. In this clinical investigation feasibility, safety and performance of the new cardiac occluder will be evaluated in accordance with European and US regulations. The study data will be compared to performance criteria for VSD, which are deduced analogue to the published specific Objective Performance Criteria (OPCs) for PDAs. The first part of the study has been performed in three clinical centres in Germany. For the second part in April 2009 four additional clinical centres in Germany, Israel, Italy and Spain were included.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00390702
Study type Interventional
Source pfm medical ag
Contact
Status Completed
Phase N/A
Start date October 2006
Completion date May 2017

See also
  Status Clinical Trial Phase
Completed NCT01480908 - Right Bundle Branch Block After Surgical Closure of Ventricular Septal Defect N/A
Completed NCT00199771 - Hypertonic Saline Dextran in Pediatric Cardiac Surgery Phase 2
Completed NCT00583791 - Closure of Muscular Ventricular Septal Defects With The AMPLATZERâ„¢ Muscular VSD Occluder N/A
Completed NCT00005190 - Reproduction and Survival After Cardiac Defect Repair N/A
Completed NCT00005546 - Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular Disease N/A
Completed NCT00005322 - Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease N/A
Recruiting NCT00173186 - Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect N/A
Withdrawn NCT01825369 - Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow Phase 1
Completed NCT02361008 - A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect N/A
Terminated NCT00113698 - Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation Phase 3
Completed NCT00000470 - Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest Phase 3
Recruiting NCT00006272 - Study of Energy Expenditure in Infants With Ventricular Septal Defects N/A